Filing step-change
SOLVEX · 2026-10
Quarterly observations that moved versus the prior period in 2026-10. Facts only — not a call to act.
Narrative date 2026-10-20 · Evidence medium
SOLVEX Sees Significant Shift in Key Metrics, With Gross Margin Accelerating to 10.38% and Marginal Operating Leverage Rising Sharply to 2.55%.
Raw Evidence
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 10.38 % | 2.55 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 2.55 % | 0.05 | ▲ |
Cite this
Source: Samhati filing step-change for SOLVEX (2026-10). Observation: SOLVEX Sees Significant Shift in Key Metrics, With Gross Margin Accelerating to 10.38% and Marginal Operating Leverage Rising Sharply to 2.55%. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/solvex/q/2026-10
Other periods